Abstract
During its development in the host red cell, the human malarial parasite causes profound alteration in the permeability of the host cell membrane. These membrane transport systems(s) play a role in the development of the intra-erythrocytic parasite in its need to take up solutes and nutrients from the extracellular medium and the disposal of metabolic wastes. Importantly, the properties of these parasite induced transport systems are significantly different from those in normal human cells. Hence, such systems are of considerable interest for their potential use in anti-malarial chemotherapy, both by (i) inhibiting the transport and hence depriving the parasite of nutrients essential for its development, or (ii) by designing cytotoxic drugs which selectively enter the parasite through these induced transporter routes and hence cannot enter normal mammalian cells. Since our discovery that optical isomers of nucleosides (such as Ladenosine or L- thymidine) were selectively transported into malaria infected cells through the induced transporter, L-nucleoside drug “carriers” were actively synthesized as potentially new therapeutic agents. The compounds are dinucleoside phosphate dimers, where each ”carrier“ (a L-nucleoside) has been conjugated to known anti-malarial agents, such as 5-fluro-uridine through the 3 and 5-OH and a phosphate group. A very large series of these drugs have been synthesized with varying conjugations. The dimers are extremely toxic against malaria and experimental evidence has confirmed that they are incapable of entering normal mammalian cells. This review discusses their mechanism of action and potential as new anti-malarial chemotherapy as well as the role played by the membrane transport system of malaria infected cells as a target for malaria chemotherapy.
Keywords: Malaria, Chemotherapy, isomers, fluro-uridine, anti-malarial agents, mammalian cells, L- thymidine
Current Pharmaceutical Design
Title: New Malaria Chemotherapy Developed by Utilization of a Unique Parasite Transport System
Volume: 9 Issue: 11
Author(s): Annette M. Gero, Catherine G. Dunn, David M. Brown, Kirupa Pulenthiran, Elena L. Gorovits, Tomas Bakos and Alexander L. Weis
Affiliation:
Keywords: Malaria, Chemotherapy, isomers, fluro-uridine, anti-malarial agents, mammalian cells, L- thymidine
Abstract: During its development in the host red cell, the human malarial parasite causes profound alteration in the permeability of the host cell membrane. These membrane transport systems(s) play a role in the development of the intra-erythrocytic parasite in its need to take up solutes and nutrients from the extracellular medium and the disposal of metabolic wastes. Importantly, the properties of these parasite induced transport systems are significantly different from those in normal human cells. Hence, such systems are of considerable interest for their potential use in anti-malarial chemotherapy, both by (i) inhibiting the transport and hence depriving the parasite of nutrients essential for its development, or (ii) by designing cytotoxic drugs which selectively enter the parasite through these induced transporter routes and hence cannot enter normal mammalian cells. Since our discovery that optical isomers of nucleosides (such as Ladenosine or L- thymidine) were selectively transported into malaria infected cells through the induced transporter, L-nucleoside drug “carriers” were actively synthesized as potentially new therapeutic agents. The compounds are dinucleoside phosphate dimers, where each ”carrier“ (a L-nucleoside) has been conjugated to known anti-malarial agents, such as 5-fluro-uridine through the 3 and 5-OH and a phosphate group. A very large series of these drugs have been synthesized with varying conjugations. The dimers are extremely toxic against malaria and experimental evidence has confirmed that they are incapable of entering normal mammalian cells. This review discusses their mechanism of action and potential as new anti-malarial chemotherapy as well as the role played by the membrane transport system of malaria infected cells as a target for malaria chemotherapy.
Export Options
About this article
Cite this article as:
Gero M. Annette, Dunn G. Catherine, Brown M. David, Pulenthiran Kirupa, Gorovits L. Elena, Bakos Tomas and Weis L. Alexander, New Malaria Chemotherapy Developed by Utilization of a Unique Parasite Transport System, Current Pharmaceutical Design 2003; 9 (11) . https://dx.doi.org/10.2174/1381612033455233
DOI https://dx.doi.org/10.2174/1381612033455233 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Assorted Applications of N-substituted-2,4-thiazolidinediones in Various Pathological Conditions
Mini-Reviews in Medicinal Chemistry P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry Artificial Intelligence in Pharmaceutical Field - A Critical Review
Current Drug Delivery New Quinolinyl–1,3,4–Oxadiazoles: Synthesis, In Vitro Antibacterial, Antifungal and Antituberculosis Studies
Medicinal Chemistry Evaluation of the Therapeutic Properties of Mastoparan- and Sifuvirtide- Derivative Antimicrobial Peptides Using Chemical Structure-Function Relationship - in vivo and in silico Approaches
Current Drug Delivery Green Solvent: Green Shadow on Chemical Synthesis
Current Organic Synthesis Natural Product Inhibitors of Hsp90: Potential Leads for Drug Discovery
Mini-Reviews in Medicinal Chemistry Fragment-Based Optimization of Small Molecule CXCL12 Inhibitors for Antagonizing the CXCL12/CXCR4 Interaction
Current Topics in Medicinal Chemistry Antimitotic Activity on Sea Urchin Embryonic Cells of Seven Antiparasitic Morita-Baylis-Hillman Adducts: A Potential New Class of Anticancer Drugs
Medicinal Chemistry Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects
Current Organic Synthesis Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design
Current Topics in Medicinal Chemistry Viral Infection - A Cure for Type 1 Diabetes?
Current Medicinal Chemistry Cholesterol-Rich Nanoemulsions (LDE) for Drug Targeting of Cholesteryl-Succinyl- 5-Fluorouracil Conjugate
Current Nanoscience Anti-cancer Drug Development: Computational Strategies to Identify and Target Proteins Involved in Cancer Metabolism
Current Pharmaceutical Design The Prediction of Carcinogenicity from Molecular Structure
Current Computer-Aided Drug Design Technological, Biochemical and Microbiological Evaluation of Dehydrated <i>Pleurotus ostreatus</i> Powder for Nutraceutical Applications
Current Nutrition & Food Science Sulfur-Containing Compounds in Protecting Against Oxidant-Mediated Lung Diseases
Current Medicinal Chemistry Advances and Challenges in the Synthesis of Highly Oxidised Natural Phenols with Antiviral, Antioxidant and Cytotoxic Activities
Current Medicinal Chemistry Current Concepts of Corticosteroids Use for the Prevention of Bronchopulmonary Dysplasia
Current Pediatric Reviews Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial
Endocrine, Metabolic & Immune Disorders - Drug Targets